Correlation Between Okta and Oramed Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Okta and Oramed Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Okta and Oramed Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Okta Inc and Oramed Pharmaceuticals, you can compare the effects of market volatilities on Okta and Oramed Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Okta with a short position of Oramed Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Okta and Oramed Pharmaceuticals.
Diversification Opportunities for Okta and Oramed Pharmaceuticals
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between Okta and Oramed is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Okta Inc and Oramed Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oramed Pharmaceuticals and Okta is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Okta Inc are associated (or correlated) with Oramed Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oramed Pharmaceuticals has no effect on the direction of Okta i.e., Okta and Oramed Pharmaceuticals go up and down completely randomly.
Pair Corralation between Okta and Oramed Pharmaceuticals
Given the investment horizon of 90 days Okta Inc is expected to under-perform the Oramed Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Okta Inc is 1.29 times less risky than Oramed Pharmaceuticals. The stock trades about -0.04 of its potential returns per unit of risk. The Oramed Pharmaceuticals is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 218.00 in Oramed Pharmaceuticals on August 29, 2024 and sell it today you would earn a total of 19.00 from holding Oramed Pharmaceuticals or generate 8.72% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Okta Inc vs. Oramed Pharmaceuticals
Performance |
| Timeline |
| Okta Inc |
| Oramed Pharmaceuticals |
Okta and Oramed Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Okta and Oramed Pharmaceuticals
The main advantage of trading using opposite Okta and Oramed Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Okta position performs unexpectedly, Oramed Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oramed Pharmaceuticals will offset losses from the drop in Oramed Pharmaceuticals' long position.The idea behind Okta Inc and Oramed Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Oramed Pharmaceuticals vs. Protalix Biotherapeutics | Oramed Pharmaceuticals vs. Corvus Pharmaceuticals | Oramed Pharmaceuticals vs. Aldeyra | Oramed Pharmaceuticals vs. Checkpoint Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |